window-to-japan.eu

Window to Japan

Astellas Pharma increases sales and profits, becomes 1 trillion Yen company

By schmid_wordpressPosted on Posted in News

Blockbuster is Vesicare (Solifenacin-succinate), a muscarine receptor blocker for the treatment of overactive bladder

Astellas news release, May 13, 2013

Astellas Pharma increases sales and profits, becomes 1 trillion Yen company
Scroll to top